Form 4: Altimmune Director Wayne Pisano Granted 48,800 Stock Options
Insider Transaction Report
Altimmune, Inc. Director Wayne Pisano received a grant of 48,800 stock options with an exercise price of $3.92, vesting over 12 months.
Summary
- Wayne Pisano, a Director of Altimmune, Inc. (ALT), was granted 48,800 stock options.
- The options have an exercise price of $3.92 per share.
- The grant date for these options was September 25, 2025.
- The options will vest in substantially equal monthly installments over 12 months, starting from September 25, 2025.
- Vesting is contingent upon Mr. Pisano's continued service to the company.
- The options expire on September 25, 2035.
Sentiment
Score: 6
Explanation: The grant of stock options to a director is generally a positive event, aligning management's interests with shareholders. It is a routine compensation event and not indicative of major operational news.
Positives
- Director Wayne Pisano received a grant of 48,800 stock options, aligning his financial interests with shareholder value creation.
- The options have a 10-year expiration date (September 25, 2035), providing a long-term incentive for the director.
Risks
- The vesting of the stock options is subject to Wayne Pisano's continued service to Altimmune, Inc., meaning unvested options could be forfeited if service ceases.
Future Outlook
The filing indicates a future vesting schedule for the granted stock options, with shares becoming exercisable in substantially equal monthly installments over 12 months following September 25, 2025, contingent on continued service.
Industry Context
This is a routine insider transaction filing (Form 4) reporting director compensation. It does not provide broader industry trends or competitive analysis.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Grant | Wayne Pisano granted a Power of Attorney to Vipin K. Garg and Gregory Weaver to execute and file SEC Forms 3, 4, 5, Schedule 13D, and 13G on his behalf. This supersedes any prior power of attorney. | 09/25/2025 | Streamlines compliance for insider reporting requirements for the director, ensuring timely and accurate filings. |
Related Party Transactions
- The grant of 48,800 stock options to Director Wayne Pisano constitutes a related party transaction, which is a standard form of executive and director compensation.
Stakeholder Impact
- Shareholders: The grant of options aligns the director's financial incentives with the company's stock performance, potentially benefiting shareholders if the stock price increases.
- Employees: No direct impact on general employees is noted in this filing.
Next Steps
- Wayne Pisano's continued service to Altimmune, Inc. is required for the options to vest.
- Monthly vesting of options will occur over 12 months starting September 25, 2025.
Key Dates
| Date | Description |
|---|---|
| 09/25/2025 | Date of earliest transaction (grant of stock options) and start of the 12-month vesting period. |
| 09/25/2035 | Expiration date of the granted stock options. |
| 09/29/2025 | Date the Form 4 was signed and filed with the SEC. |
Keywords
Altimmune, ALT, Stock Options, Insider Transaction, Form 4, Director Compensation, Equity Grant, Wayne Pisano
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.